Company profile
NG Bio
NG Bio, an early-stage investor and venture builder addressing harmful immune responses.
- Industry
- Venture Capital and Private Equity Principals
- Employees
- 6
- Headquarters
- London
- Founded
- 2020
- Office locations
- 1
NG Bio company summary
NG Bio is a company in the Venture Capital and Private Equity Principals industry, headquartered in London, founded in 2020. On LinkedIn the company has around 6 employees. Its listed specialties include Autoimmune and Chronic Inflammatory Diseases, Drug Development, Therapeutic Venture Builder, Immunology, Investor.
What technology does NG Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NG Bio
NG Bio, an early-stage investor and venture builder addressing the harmful immune responses, such as inflammation, that cause or exacerbate many of the major human diseases. By tackling these, we extend human health span and longevity. As scientists continue to unlock the secrets to the drivers of inflammation, NG Bio is creating the next generation of medicines and diagnostics in the breakthrough areas of cure, personalisation, regeneration, and women’s health. We partner with world leading entrepreneurs, research institutions and academic institutions across the globe to realise our vision of life with control over chronic diseases.
Specialties
Where is NG Bio located?
NG Bio lists 1 location.
Compare companies similar to NG Bio
More companies in Venture Capital and Private Equity Principals.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NG Bio ngbio.co.uk | Venture Capital and Private Equity Principals | 6 | 2020 | London |
 Sequoia Capital sequoiacap.com | Venture Capital and Private Equity Principals | 347 | - | Menlo Park, CA |
 Andreessen Horowitz a16z.com | Venture Capital and Private Equity Principals | 1,030 | 2009 | Menlo Park, CA |
 Private Equity Insights pe-insights.com | Venture Capital and Private Equity Principals | 1,579 | 2013 | London, England |
 500 Global 500.co | Venture Capital and Private Equity Principals | 2,686 | 2010 | Palo Alto, California, US |
 Techstars techstars.com | Venture Capital and Private Equity Principals | 2,610 | 2006 | New York City, New York |
 Accel accel.com | Venture Capital and Private Equity Principals | 1,411 | - | Palo Alto, CA |
 Virgin virgin.com | Venture Capital and Private Equity Principals | 36,222 | - | London, England |
 Conscience VC conscience.vc | Venture Capital and Private Equity Principals | 2,001 | 2020 | Austin, TX |
 Peak XV Partners peakxv.com | Venture Capital and Private Equity Principals | 206 | - | Bangalore, Karnataka, IN |
 Greylock Partners greylock.com | Venture Capital and Private Equity Principals | 132 | - | Menlo Park, CA, US |
Frequently asked questions about NG Bio
What does NG Bio do?
NG Bio, an early-stage investor and venture builder addressing the harmful immune responses, such as inflammation, that cause or exacerbate many of the major human diseases. By tackling these, we extend human health span and longevity. As scientists continue to unlock the secrets to the drivers of inflammation, NG Bio is creating the next generation of medicines and diagnostics in the breakthrough areas of cure, personalisation, regeneration, and women’s health. We partner with world leading entrepreneurs, research institutions and academic institutions across the globe to realise our vision of life with control over chronic diseases.
How many employees does NG Bio have?
NG Bio has around 6 employees on LinkedIn.
Where is NG Bio headquartered?
NG Bio is headquartered in London.
When was NG Bio founded?
NG Bio was founded in 2020.
Build a lead list from companies like NG Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.